Exelixis, Inc. - Common Stock — Cash Flow (NASDAQ:EXEL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 400.8 M362.61 M333.32 M699.97 M884.27 M 924.67 M Cash from investing activities -42.88 M-524.41 M-26.95 M-116.78 M350.44 M 249.61 M Cash from financing activities -14.8 M586 K-546.05 M-628.81 M-969.59 M -1.13 B Free cash flow 400.8 M362.61 M333.32 M699.97 M884.27 M 924.67 M

News

Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare

Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN

EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?

Stocks Look Shaky, But This Sector is Booming (Biotech)

Here's Why Exelixis (EXEL) is a Strong Growth Stock

Exelixis: STELLAR-303 Results Mixed, STELLAR-304 Success Likely (NASDAQ:EXEL)

EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?

Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?

Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists

Arista Networks, Morgan Stanley Among 15 New Stocks On IBD Watchlists

Why Exelixis (EXEL) is a Top Value Stock for the Long-Term

GE Aerospace Hits Record High, Leads 19 Onto IBD 50, Big Cap 20, Other Best Stock Lists